Phase I/II Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Conditions:   Non Hodgkin Lymphoma;   Mantle Cell Lymphoma Interventions:   Biological: 8-Day Production of Car-T Cells;   Biological: 12-Day Production of Car-T Cells Sponsor:   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials